Trial record 2 of 25 for:    gene therapy | Sickle Cell Disease

Gene Transfer for Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03282656
Recruitment Status : Recruiting
First Posted : September 14, 2017
Last Update Posted : May 24, 2018
Information provided by (Responsible Party):
David Williams, Boston Children’s Hospital

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : February 13, 2020
  Estimated Study Completion Date : February 13, 2024